scispace - formally typeset
L

Linda Chang

Researcher at University of Maryland, Baltimore

Publications -  276
Citations -  23444

Linda Chang is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Working memory & Methamphetamine. The author has an hindex of 81, co-authored 267 publications receiving 20430 citations. Previous affiliations of Linda Chang include Brookhaven National Laboratory & University of Hawaii at Manoa.

Papers
More filters
Journal ArticleDOI

Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers

TL;DR: Evidence is provided that methamphetamine at dose levels taken by human abusers of the drug leads to dopamine transporter reduction that is associated with motor and cognitive impairment and the urgency of alerting clinicians and the public of the long-term changes that methamphetamine can induce in the human brain.
Journal ArticleDOI

Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex

TL;DR: The association between level of dopamine D2 receptors and metabolism in the orbit ofrontal cortex in methamphetamine abusers suggests that D2 receptor-mediated dysregulation of the orbitofrontal cortex could underlie a common mechanism for loss of control and compulsive drug intake in drug-addicted subjects.
Journal ArticleDOI

Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence

TL;DR: It is suggested that protracted abstinence may reverse some of methamphetamine-induced alterations in brain DA terminals, and neuropsychological tests did not improve to the same extent as during short abstinence, which suggests that the increase of the DA transporters was not sufficient for complete function recovery.
Journal ArticleDOI

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

TL;DR: It is interesting that CSF Aβ42 levels were found to be significantly lower in AD patients relative to controls, whereas total Aβ levels were not, and neither A β42 nor τ levels were apparently influenced by the ApoE genotype.